Yaohai Bio-Pharma, founded in 2010, is a CRDMO specializing in microbial expression systems. We focus on the development and manufacturing of recombinant proteins, plasmids, nano-bodies, vaccines, mRNA, and circRNA, providing integrated CRO/CDMO/MAH services across the entire biologics lifecycle.
Integer quam lacinia nibh erat nam. Lobortis nec ullamcorper tincidunt ante feugiat curabitur dui nulla tempus luctus sapien. Sollicitudin ullamcorper iaculis ipsum dui lorem nostra velit parturient semper penatibus.
Yaohai Bio-Pharma is ISO-certified and EU QP-audited, reflecting our firm commitment to global quality standards and service excellence.
Yaohai Bio-Pharma delivers tailored CRDMO solutions for global clients, meeting diverse project requirements with excellence and efficiency.
Proven track record of over 200 successful projects, spanning preclinical studies and Phase I/II/III clinical trials, including US–China dual submissions and Australian regulatory filings.
A robust GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines across the entire product lifecycle.
Powered by industry-leading scientists and cross-functional experts, our team delivers CRDMO projects with speed, precision, and deep technical insight.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi